Literature DB >> 22068459

Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

L Lyon1, L M Saksida, T J Bussey.   

Abstract

RATIONALE: Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits.
OBJECTIVES: We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia-the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems-alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia.
RESULTS: Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT(6) antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT.
CONCLUSIONS: While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068459     DOI: 10.1007/s00213-011-2536-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  287 in total

1.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Authors:  Susheel Vijayraghavan; Min Wang; Shari G Birnbaum; Graham V Williams; Amy F T Arnsten
Journal:  Nat Neurosci       Date:  2007-02-04       Impact factor: 24.884

2.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

Review 3.  Working memory dysfunction in schizophrenia.

Authors:  P S Goldman-Rakic
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

4.  PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia.

Authors:  Pooja Sood; Nagi F Idris; Susan Cole; Ben Grayson; Joanna C Neill; Andrew M J Young
Journal:  J Psychopharmacol       Date:  2010-11-18       Impact factor: 4.153

5.  A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients.

Authors:  Zhijun Zhang; Jing Sun; Gavin P Reynolds
Journal:  Chin Med J (Engl)       Date:  2002-06       Impact factor: 2.628

6.  Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.

Authors:  Junji Ichikawa; Zhu Li; Jin Dai; Herbert Y Meltzer
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

Review 7.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia.

Authors:  Onder Tuğal; Kâzm M Yazici; A Elif Anil Yağcioğlu; Ahmet Göğüş
Journal:  Int J Neuropsychopharmacol       Date:  2004-01-23       Impact factor: 5.176

10.  Medial prefrontal cortex is involved in spatial temporal order memory but not spatial recognition memory in tests relying on spontaneous exploration in rats.

Authors:  D K Hannesson; G Vacca; J G Howland; A G Phillips
Journal:  Behav Brain Res       Date:  2004-08-12       Impact factor: 3.332

View more
  38 in total

1.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.

Authors:  A Potasiewicz; T Kos; F Ravazzini; G Puia; H R Arias; P Popik; A Nikiforuk
Journal:  Br J Pharmacol       Date:  2015-10-10       Impact factor: 8.739

3.  Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.

Authors:  Eric R Detrait; Greg V Carr; Daniel R Weinberger; Yves Lamberty
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

4.  Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.

Authors:  Pothitos M Pitychoutis; Arnauld Belmer; Imane Moutkine; Joëlle Adrien; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

5.  Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine.

Authors:  Indrani Poddar; Patrick M Callahan; Caterina M Hernandez; Xiangkun Yang; Michael G Bartlett; Alvin V Terry
Journal:  Biochem Pharmacol       Date:  2017-11-24       Impact factor: 5.858

6.  Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.

Authors:  Patrick M Callahan; Alvin V Terry; Ashok Tehim
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

Review 7.  Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

8.  New automated procedure to assess context recognition memory in mice.

Authors:  David Reiss; Ondine Walter; Lucie Bourgoin; Brigitte L Kieffer; Abdel-Mouttalib Ouagazzal
Journal:  Psychopharmacology (Berl)       Date:  2014-04-27       Impact factor: 4.530

9.  Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.

Authors:  Nino Muradashvili; Richard L Benton; Kathryn E Saatman; Suresh C Tyagi; David Lominadze
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

10.  Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.

Authors:  Brittney R Lins; Stephanie A Ballendine; John G Howland
Journal:  Neurosci Lett       Date:  2013-12-17       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.